(MDLZ) Mondelez International - Overview
Stock: Biscuits, Chocolate, Candy, Cheese, Beverages
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.12% |
| Yield on Cost 5y | 3.98% |
| Yield CAGR 5y | 9.90% |
| Payout Consistency | 96.8% |
| Payout Ratio | 68.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Relative Tail Risk | -3.14% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -1.21 |
| Character TTM | |
|---|---|
| Beta | 0.083 |
| Beta Downside | -0.082 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.14% |
| CAGR/Max DD | -0.08 |
Description: MDLZ Mondelez International January 29, 2026
Mondelez International (NASDAQ: MDLZ) is a global snack-food company that sells biscuits, crackers, snack bars, chocolates, gums, candies and assorted grocery and beverage items across the Americas, Europe, Asia, the Middle East and Africa. Its portfolio includes household names such as Oreo, Ritz, LU, CLIF Bar, Cadbury Dairy Milk, Milka and Toblerone, and its distribution reaches supermarkets, convenience stores, club stores, e-retail platforms and direct-to-consumer channels.
Key recent metrics: • FY 2023 net sales were $31.5 billion, a 2.8 % increase YoY, driven primarily by a 5 % rise in emerging-market volumes. • Q1 2024 comparable sales grew 4 % YoY, with e-commerce accounting for roughly 12 % of total sales, up 1.5 percentage points from the prior year. • Operating margin held steady at ~15 % despite higher commodity costs, while the company’s free-cash-flow conversion remained above 80 % of net income.
Sector drivers that materially affect MDLZ include: • Global snack-food demand is projected to grow 3-4 % annually through 2027, supported by rising disposable income in emerging economies and a shift toward on-the-go consumption. • Inflationary pressure on key inputs (cocoa, wheat, palm oil) has compressed margins across the packaged-foods industry, prompting firms to accelerate cost-pass-through and reformulate products. • The continued expansion of digital grocery and direct-to-consumer sales channels is reshaping distribution economics, with the top-quartile players capturing an additional 2-3 % of total revenue share.
For a deeper quantitative assessment, you might explore the MDLZ valuation model on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 3.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.92 > 1.0 |
| NWC/Revenue: -22.22% < 20% (prev -21.78%; Δ -0.45% < -1%) |
| CFO/TA 0.05 > 3% & CFO 3.58b > Net Income 3.53b |
| Net Debt (20.57b) to EBITDA (5.60b): 3.67 < 3 |
| Current Ratio: 0.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.30b) vs 12m ago -3.01% < -2% |
| Gross Margin: 31.05% > 18% (prev 0.39%; Δ 3067 % > 0.5%) |
| Asset Turnover: 52.45% > 50% (prev 50.08%; Δ 2.37% > 0%) |
| Interest Coverage Ratio: 9.76 > 6 (EBITDA TTM 5.60b / Interest Expense TTM 437.0m) |
Altman Z'' 1.87
| A: -0.12 (Total Current Assets 13.15b - Total Current Liabilities 21.51b) / Total Assets 71.36b |
| B: 0.51 (Retained Earnings 36.39b / Total Assets 71.36b) |
| C: 0.06 (EBIT TTM 4.26b / Avg Total Assets 71.77b) |
| D: 0.55 (Book Value of Equity 24.93b / Total Liabilities 45.13b) |
| Altman-Z'' Score: 1.87 = BBB |
Beneish M -2.72
| DSRI: 1.07 (Receivables 5.24b/4.69b, Revenue 37.65b/36.15b) |
| GMI: 1.25 (GM 31.05% / 38.77%) |
| AQI: 0.98 (AQ_t 0.66 / AQ_t-1 0.67) |
| SGI: 1.04 (Revenue 37.65b / 36.15b) |
| TATA: -0.00 (NI 3.53b - CFO 3.58b) / TA 71.36b) |
| Beneish M-Score: -2.72 (Cap -4..+1) = A |
What is the price of MDLZ shares?
Over the past week, the price has changed by -0.47%, over one month by +5.08%, over three months by -0.02% and over the past year by +3.48%.
Is MDLZ a buy, sell or hold?
- StrongBuy: 11
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MDLZ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67 | 16.9% |
| Analysts Target Price | 67 | 16.9% |
| ValueRay Target Price | 58.7 | 2.4% |
MDLZ Fundamental Data Overview January 29, 2026
P/E Forward = 18.797
P/S = 2.0287
P/B = 2.9093
P/EG = 5.4534
Revenue TTM = 37.65b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 5.60b USD
Long Term Debt = 17.13b USD (from longTermDebt, last quarter)
Short Term Debt = 4.19b USD (from shortTermDebt, last quarter)
Debt = 21.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.57b USD (from netDebt column, last quarter)
Enterprise Value = 96.93b USD (76.37b + Debt 21.93b - CCE 1.37b)
Interest Coverage Ratio = 9.76 (Ebit TTM 4.26b / Interest Expense TTM 437.0m)
EV/FCF = 42.33x (Enterprise Value 96.93b / FCF TTM 2.29b)
FCF Yield = 2.36% (FCF TTM 2.29b / Enterprise Value 96.93b)
FCF Margin = 6.08% (FCF TTM 2.29b / Revenue TTM 37.65b)
Net Margin = 9.38% (Net Income TTM 3.53b / Revenue TTM 37.65b)
Gross Margin = 31.05% ((Revenue TTM 37.65b - Cost of Revenue TTM 25.95b) / Revenue TTM)
Gross Margin QoQ = 26.81% (prev 32.69%)
Tobins Q-Ratio = 1.36 (Enterprise Value 96.93b / Total Assets 71.36b)
Interest Expense / Debt = 0.10% (Interest Expense 22.0m / Debt 21.93b)
Taxrate = 15.52% (137.0m / 883.0m)
NOPAT = 3.60b (EBIT 4.26b * (1 - 15.52%))
Current Ratio = 0.61 (Total Current Assets 13.15b / Total Current Liabilities 21.51b)
Debt / Equity = 0.84 (Debt 21.93b / totalStockholderEquity, last quarter 26.18b)
Debt / EBITDA = 3.67 (Net Debt 20.57b / EBITDA 5.60b)
Debt / FCF = 8.98 (Net Debt 20.57b / FCF TTM 2.29b)
Total Stockholder Equity = 26.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.92% (Net Income 3.53b / Total Assets 71.36b)
RoE = 13.44% (Net Income TTM 3.53b / Total Stockholder Equity 26.27b)
RoCE = 9.82% (EBIT 4.26b / Capital Employed (Equity 26.27b + L.T.Debt 17.13b))
RoIC = 7.81% (NOPAT 3.60b / Invested Capital 46.15b)
WACC = 4.85% (E(76.37b)/V(98.30b) * Re(6.22%) + D(21.93b)/V(98.30b) * Rd(0.10%) * (1-Tc(0.16)))
Discount Rate = 6.22% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -2.24%
[DCF Debug] Terminal Value 86.05% ; FCFF base≈2.85b ; Y1≈2.78b ; Y5≈2.78b
Fair Price DCF = 48.54 (EV 83.20b - Net Debt 20.57b = Equity 62.64b / Shares 1.29b; r=5.90% [WACC]; 5y FCF grow -3.84% → 2.90% )
EPS Correlation: -39.65 | EPS CAGR: -48.68% | SUE: -4.0 | # QB: 0
Revenue Correlation: 80.76 | Revenue CAGR: 6.63% | SUE: 0.23 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.77 | Chg30d=-0.015 | Revisions Net=-2 | Analysts=14
EPS next Year (2026-12-31): EPS=3.14 | Chg30d=-0.008 | Revisions Net=-4 | Growth EPS=+8.5% | Growth Revenue=+3.8%